![European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine](https://kongres-magazine.eu/wp-content/uploads/2017/02/IMG_4737-800x600.jpg)
European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2d8ce941-c21d-47d2-bfdc-8ad0f0503aac/gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
![PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis](https://i1.rgstatic.net/publication/323614047_2nd_N-ECCO_Consensus_Statements_on_the_European_Nursing_Roles_in_Caring_for_Patients_with_Crohn's_Disease_or_Ulcerative_Colitis/links/5ad0e854458515c60f4f34f3/largepreview.png)
PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis
横浜市立大学 消化器内科学教室 - 2016/2/14-17 ECCO 2018 in Vienna ウィーンで開催されたEuropean Crohn's and Colitis Organisation Congress 2018にて,当教室から附属市民総合医療センター IBDセンター の西尾 匡史 大学院生が発表を行いました ...
![PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors](https://i1.rgstatic.net/publication/322894972_P374_Non-alcoholic_fatty_liver_disease_in_inflammatory_bowel_disease_Prevalence_and_risk_factors/links/5ac8d953a6fdcc8bfc823559/largepreview.png)
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
![PDF) Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey PDF) Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey](https://i1.rgstatic.net/publication/274258279_Internet-orientated_Assessment_of_QOL_and_Actual_Treatment_Status_in_Japanese_Patients_with_Inflammatory_Bowel_Disease_The_3I_survey/links/5c0912e192851c39ebd77106/largepreview.png)
PDF) Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey
![Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/04/Patient-Centricity-in-IBD-Treatment-An-Interview-with-Dr-Corey-Siegel-at-the-13th-Congress-of-ECCO-940x564.jpg)
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal
1 ECCO-ESGAR Guideline for Diagnostics in Inflammatory Bowel Disease Agreed Author-List order: Note: Affiliations will be insert
![PDF) Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN PDF) Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN](https://i1.rgstatic.net/publication/323832910_Corrigendum_Vedolizumab_in_Paediatric_Inflammatory_Bowel_Disease_A_Retrospective_Multi-Centre_Experience_From_the_Paediatric_IBD_Porto_Group_of_ESPGHAN/links/5acdfed2aca2723a33411e30/largepreview.png)